11 employees
Crossbow Therapeutics expands cancer treatment through potent and precise antibody therapies, targeting a vast range of cancer antigens.
2021
$80M
from 2 investors over 2 rounds
Crossbow Therapeutics, Inc raised $80M on July 11, 2023
Investors: MPM Capital and Polaris Partners